All are true about Exenatide except -: (A) Decreases glucagon secretion, (B) It is GLP 1 analogue, (C) Used in type 1 DM, (D) Given subcutaneously
Answer is C. Ans. is 'c' i.e., Used in type I diabetes mellitus Exenatide is a synthetic glucagon-like peptide -1 (GLP-l) analogue. o It acts similar to GLP-1 --> Enhancement of postprandial insulin release, suppression of glucagon release and appetite as well as slowing of gastric emptying. o It is given by subcutaneous route & used in type 2 DM